Tobacco Use Cessation Clinical Trial
Official title:
Implementation of an Automated EMR System to Connect Smokers in a Safety Net Healthcare System With Smoking Cessation Treatment
Verified date | May 2019 |
Source | M.D. Anderson Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The goal of this behavioral research study is to learn about the outcomes of smoking cessation treatment. Researchers want to learn how many smokers stopped smoking after taking part in smoking cessation treatment with the Texas Quitline.
Status | Active, not recruiting |
Enrollment | 5212 |
Est. completion date | April 2049 |
Est. primary completion date | April 2049 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. 18 years of age or older 2. Self-reported current smoker 3. Present for care at one of the 13 Harris Health System (HHS) community clinics 4. Has a working telephone number Exclusion Criteria: 1) None |
Country | Name | City | State |
---|---|---|---|
United States | Harris Health System | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
M.D. Anderson Cancer Center | Cancer Therapy and Research Center, Texas |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluate the Reach of Ask Advise Connect (AAC) Smoking Cessation Program | Reach defined as the proportion of smokers that enroll in treatment with the Quitline. To evaluate the reach of AAC, we will calculate the proportion of smokers seen at the 13 Harris Health System community health clinics during the two-year treatment dissemination period that enroll in treatment with the Quitline. | 2 years | |
Secondary | Efficacy of Ask Advise Connect (AAC) Smoking Cessation Program | Efficacy is defined as the proportion of smokers who agree to be connected to the Quitline that enroll in treatment who successfully achieve abstinence assessed 6 months following treatment enrollment. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06021652 -
Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening
|
N/A | |
Completed |
NCT02735382 -
EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study
|
N/A | |
Completed |
NCT02557919 -
Families Reduce Exposure to Smoke at Home
|
N/A | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Completed |
NCT00786149 -
Improving Varenicline Adherence and Outcomes in Homeless Smokers
|
Phase 3 | |
Completed |
NCT00387946 -
Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)
|
Phase 3 | |
Completed |
NCT00218452 -
Smoking Cessation for Young Adults Who Binge Drink - 1
|
Phase 0 | |
Completed |
NCT00124683 -
Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1
|
Phase 2 | |
Recruiting |
NCT04610931 -
Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation
|
N/A | |
Enrolling by invitation |
NCT06042361 -
Enhancing Equity in Smoke-free Housing
|
N/A | |
Recruiting |
NCT04827420 -
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
|
N/A | |
Recruiting |
NCT04994444 -
Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts
|
Phase 2/Phase 3 | |
Completed |
NCT05560243 -
Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil
|
N/A | |
Completed |
NCT02721082 -
Changing the Default for Tobacco Treatment
|
Phase 4 | |
Completed |
NCT01885221 -
A Multi-Media Approach to Partner Support in Smokeless Tobacco Cessation (UCare-ChewFree)
|
N/A | |
Completed |
NCT03445507 -
Effectiveness of a Chat Bot for Smoking Cessation: a Pragmatic Trial in Primary Care.
|
N/A | |
Completed |
NCT04540081 -
Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer
|
N/A | |
Completed |
NCT03714191 -
Optimizing the Tobacco Cessation Clinical Decision Support Tool.
|
||
Completed |
NCT03553992 -
An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers
|
N/A | |
Completed |
NCT01699828 -
Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET
|
Phase 1/Phase 2 |